Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production.
暂无分享,去创建一个
R. DeFronzo | M. Abdul-Ghani | G. Daniele | C. Solis-Herrera | L. Norton | D. Tripathy | T. V. Fiorentino | R. Eldor | Aurora Merovci | J. Xiong | Zandra Perez
[1] R. DeFronzo,et al. A Test of the Hypothesis that the Rate of Fall in Glucose Concentration Triggers Counterregulatory Hormonal Responses in Man , 1977, Diabetes.
[2] M. Matsuda,et al. Effect of sustained physiologic hyperinsulinaemia and hyperglycaemia on insulin secretion and insulin sensitivity in man , 1994, Diabetologia.
[3] R. DeFronzo,et al. Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. , 1989, Metabolism: clinical and experimental.
[4] R. Steele,et al. Measurement of size and turnover rate of body glucose pool by the isotope dilution method. , 1956, The American journal of physiology.
[5] R. DeFronzo,et al. Dose-response effect of elevated plasma free fatty acid on insulin signaling. , 2005, Diabetes.
[6] Influence of insulin treatment on insulin sensitivity in insulin requiring type 2 diabetes patients. , 2005, Diabetes research and clinical practice.
[7] D. Edgerton,et al. Current strategies for the inhibition of hepatic glucose production in type 2 diabetes. , 2009, Frontiers in bioscience.
[8] L. Groop,et al. Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. , 1989, The Journal of clinical investigation.
[9] H. Yki-Jărvinen,et al. Mechanisms of Hyperglycemia-Induced Insulin Resistance in Whole Body and Skeletal Muscle of Type I Diabetic Patients , 1992, Diabetes.
[10] G. Striker. Glucose toxicity. , 2001, Kidney International.
[11] G. King,et al. Microvascular complications of diabetes. , 2004, Endocrinology and metabolism clinics of North America.
[12] P. Flakoll,et al. Effects of hyperglycemia, glucagon, and epinephrine on renal glucose release in the conscious dog. , 2004, Metabolism: clinical and experimental.
[13] J. A. Scarlett,et al. Insulin Treatment Reverses the Insulin Resistance of Type II Diabetes Mellitus , 1982, Diabetes Care.
[14] F. Renström,et al. In vitro reversal of hyperglycemia normalizes insulin action in fat cells from type 2 diabetes patients: is cellular insulin resistance caused by glucotoxicity in vivo? , 2003, Metabolism: clinical and experimental.
[15] J. Holst,et al. Examining the effects of hyperglycemia on pancreatic endocrine function in humans: evidence for in vivo glucotoxicity. , 2012, The Journal of clinical endocrinology and metabolism.
[16] J. Burén,et al. Insulin resistance, endocrine function and adipokines in type 2 diabetes patients at different glycaemic levels: potential impact for glucotoxicity in vivo , 2006, Clinical endocrinology.
[17] R. DeFronzo,et al. Regulation of hepatic glucose metabolism in humans. , 1987, Diabetes/metabolism reviews.
[18] Alan G. E. Wilson,et al. LX4211, a Dual SGLT1/SGLT2 Inhibitor, Improved Glycemic Control in Patients With Type 2 Diabetes in a Randomized, Placebo-Controlled Trial , 2012, Clinical pharmacology and therapeutics.
[19] J. Zierath,et al. Effects of glycaemia on glucose transport in isolated skeletal muscle from patients with NIDDM: in vitro reversal of muscular insulin resistance , 1994, Diabetologia.
[20] P. Garlick,et al. Insulin regulation of renal glucose metabolism in humans. , 1999, American journal of physiology. Endocrinology and metabolism.
[21] A. Cherrington,et al. Banting Lecture 1997. Control of glucose uptake and release by the liver in vivo. , 1999, Diabetes.
[22] R. DeFronzo,et al. Erratum: Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production (Journal of Clinical Investigation (2014) 124:2 (509-514) DOI:10.1172/JCI70704) , 2014 .
[23] R. DeFronzo,et al. Glucose clamp technique: a method for quantifying insulin secretion and resistance. , 1979, The American journal of physiology.
[24] M. Matsuda,et al. Glucagon dose-response curve for hepatic glucose production and glucose disposal in type 2 diabetic patients and normal individuals. , 2002, Metabolism: clinical and experimental.
[25] J. Gerich,et al. Role of the kidney in hyperglycemia in type 2 diabetes , 2002, Current diabetes reports.
[26] R. DeFronzo,et al. The Effect of Insulin on the Disposal of Intravenous Glucose: Results from Indirect Calorimetry and Hepatic and Femoral Venous Catheterization , 1981, Diabetes.
[27] R. DeFronzo,et al. Role of sodium-glucose cotransporter 2 (SGLT 2) inhibitors in the treatment of type 2 diabetes. , 2011, Endocrine reviews.
[28] R. DeFronzo,et al. Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats. , 1987, The Journal of clinical investigation.